Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Interleukin-1 receptor-associated kinase 4 | ||
Ligand | BDBM388449 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Kinase Assay | ||
IC50 | 19.0±n/a nM | ||
Citation | Altman, MD; Andresen, BM; Brubaker, JD; Donofrio, A; Fischmann, T; Gibeau, CR; Lesburg, CA; Lim, J; Maclean, JK; Mansoor, UF; Northrup, AB; Sanders, JM; Smith, GF; Torres, L Inhibitors of IRAK4 activity US Patent US9943516 Publication Date 4/17/2018 | ||
More Info.: | Get all data from this article, Assay Method | ||
Interleukin-1 receptor-associated kinase 4 | |||
Name: | Interleukin-1 receptor-associated kinase 4 | ||
Synonyms: | IRAK-4 | IRAK4 | IRAK4_HUMAN | Interleukin-1 receptor-associated kinase 4 (IRAK-4) | Interleukin-1 receptor-associated kinase 4 (IRAK4) | Renal carcinoma antigen NY-REN-64 | ||
Type: | Protein | ||
Mol. Mass.: | 51519.08 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q9NWZ3 | ||
Residue: | 460 | ||
Sequence: |
| ||
BDBM388449 | |||
n/a | |||
Name | BDBM388449 | ||
Synonyms: | 6-cyclohexyl-N- (trans-4- morpholin-4- ylcyclohexyl) quinazolin-4-amine | US9943516, 1-8 | ||
Type | Small organic molecule | ||
Emp. Form. | C24H34N4O | ||
Mol. Mass. | 394.553 | ||
SMILES | C1CCC(CC1)c1ccc2ncnc(N[C@H]3CC[C@@H](CC3)N3CCOCC3)c2c1 |r,wU:18.22,wD:15.15,(-.38,8,;.39,6.66,;-.38,5.33,;-1.92,5.33,;-2.69,6.66,;-1.92,8,;-2.69,4,;-4.23,4,;-5,2.66,;-4.23,1.33,;-5,-0,;-4.23,-1.34,;-2.69,-1.34,;-1.92,-0,;-.38,-0,;.39,-1.34,;-.38,-2.67,;.39,-4,;1.92,-4,;2.69,-2.67,;1.92,-1.34,;2.69,-5.33,;1.92,-6.66,;2.69,-8,;4.23,-8,;5,-6.66,;4.23,-5.33,;-2.69,1.33,;-1.92,2.66,)| | ||
Structure |